logo

For the Inventor, By the Inventor

Bucheon, South Korea

Kun Na

This inventor holds 11 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Institute for Basic Science, Taewoong Medical Co., Ltd., The Catholic University of Korea Industry-Academic. Active years: 2011-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kun Na. Retrieved from https://idiyas.com/inventor/kun-na

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 

% Patents Active = 72.7

 

Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 34(Granted Patents)


Location History:

  • Bucheon-si, KR (2011 - 2017)
  • Gyeonggi-do, KR (2015 - 2017)

Company Filing History:

goldMedal2 out of 99 
 
Institute for Basic Science
 patents
silverMedal2 out of 37 
 
Taewoong Medical Co., Ltd.
 patents
bronzeMedal2 out of 2 
 
The Catholic University of Korea Industry-Academic
 patents
4. 1 out of 1 
 
Cathloic University Industry Academic Cooperation Foundation
 patent
5. 1 out of 1 
 
Enbiar Inc.
 patent
6. 1 out of 6 
 
H&a Pharmachem Co., Ltd
 patents
7. 1 out of 97 
 
Hanwha Chemical Corporation
 patents
8. 1 out of 2 
 
Kyong-Min Shin
 patents
9. 1 out of 2 
 
Panaxem Co., Ltd.
 patents
10. 1 out of 1 
 
Pce Tech Co., Ltd.
 patent
11. 1 out of 1 
 
Snr R&db Foundation
 patent
12. 1 out of 549 
 
Snu Rdb Foundation
 patents
13. 1 out of 118 
 
The Catholic University of Korea
 patents
14. 1 out of 834,453 
Other
 patents
where one patent can have more than one assignee

Years Active: 2011-2025

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents
1. 12409150 - pH-sensitive carbon nanoparticles, preparation method therefor, and drug delivery using same (2025-09-09),
2. 12138308 - Polymer composite for helicobacter pylori recognition and composition for photodynamic therapy comprising same (2024-11-12),
3. 9827313 - Self-assembled pharmaceutical composition for photodynamic therapy (2017-11-28),
4. 9765335 - Gene nanocomposite, and cellular internalization method of gene using same (2017-09-19),
5. 9765187 - MRI contrasting agent for contrasting cancer cell (2017-09-19),
6. 9457083 - Liposome composition for treating acne containing conjugate of lysophosphatidylcholine and chlorin e6 (2016-10-04),
7. 9169355 - Biocompatible agent for dispersing nanoparticles into an aqueous medium using mussel adhesive protein-mimetic polymer (2015-10-27),
8. 9072782 - Gadolinium complex, method for preparing same, and MRI contrast agent comprising same (2015-07-07),
9. 8946394 - Conjugate for photodynamic diagnosis or therapy and method for preparing same (2015-02-03),
10. 8017143 - Coating agent for drug releasing stent, preparation method thereof and drug releasing stent coated therewith (2011-09-13),
11. 7994213 - Coating agent for drug releasing stent, preparation method thereof and drug releasing stent coated therewith (2011-08-09),

Title: Biography of Inventor Kun Na

Introduction

Kun Na is a prominent inventor based in Bucheon-si, South Korea. He has made significant contributions to the field of nanotechnology and drug delivery systems, holding a total of 11 patents. His innovative work focuses on developing advanced materials for medical applications.

Latest Patents

Among his latest patents are pH-sensitive carbon nanoparticles and a preparation method for drug delivery using these nanoparticles. This invention relates to the creation of pH-sensitive carbon nanoparticles that can encapsulate hydrophobic drugs and photosensitizer materials. The drug release is facilitated under weakly acidic conditions, making it suitable for use as a drug carrier in anticancer treatments, photodynamic therapy, and photomediated anticancer immunotherapy. Another notable patent involves a polymer composite designed for recognizing Helicobacter pylori, which includes a water-soluble polymer-photosensitizer complex that effectively detects the strain in the gastrointestinal tract and provides photodynamic therapy to address antibiotic resistance issues.

Career Highlights

Kun Na has worked with notable organizations such as Taewoong Medical Co., Ltd. and The Catholic University of Korea Industry-Academic Cooperation. His experience in these institutions has allowed him to advance his research and development efforts in the medical field.

Collaborations

Throughout his career, Kun Na has collaborated with esteemed colleagues, including Taeghwan Hyeon and Daishun Ling.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…